Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

US Rogosin Institute invests in MAD for Cancer

The US research institute, Rogosin Institute, invests in the Lund-based research program MAD for Cancer.
Rogosin institute

The agreement gives the cancer research at Lund University new funds. Rogosin Institute has developed a general method to stop tumor growth, and the approach is to contain the tumor cells in particles of sugar and thereby produce proteins that stops the growth of tumor cells. Rogosin Institute is involved in this cooperation with  MAD for Cancer to be able to map the mechanisms underlying treatment. 

For us it is very flattering and a very good rating for cancer research in Lund, says Carl Borrebaeck, Professor at Immunotechnology and Director at CREATE Health.

It is mainly the MAD for Cancer technology for protein analysis, led by Professor Peter James, that Rogosin Institute is interested in.
- We have better equipment and more experience here in Lund than Rogosin themselves.

The first phase of the collaboration will be completed within a year and  MAD for Cancer receives funding of between two and three million Swedish kronor.
- If ithis goes well, we will go on with the cooperation and the next phase gives us a much larger investment, says Carl Borrebaeck.

Professor Barry Smith, CEO of Rogosin Institute says;
– MAD for Cancer is especially attractive for Rogosin becuause of it´s multifaceted approach to cancer system biology. This is an exciting and important opportunity for cooperation since we are going to be able to further develop our cancer project through this agreement. We feel priviliged to work with the team behind MAD for Cancer.

The program MAD for Cancer  was started by Carl Borrebaeck almost two years ago and brings together cancer research from four faculties at Lund University.

Read the Swedish news here.

Latest articles

18/09/2017
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
29/08/2017
Improved gene analysis of kidney cancer defines kidney cancer subtypes
Improved gene analysis of kidney cancer defines kidney cancer subtypes
13/06/2016
New variants of blood cancer in children
New variants of blood cancer in children
04/05/2016
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
08/04/2016
CREATE Health research in "Cancerfondsrapporten 2016"
CREATE Health research in "Cancerfondsrapporten 2016"